CRISPR in the Clinic: Gene-Editing Therapies Transforming Disease Treatment and Patient Lives

In late 2023, a groundbreaking milestone was achieved with the first-ever approval of a CRISPR-based medicine, Casgevy, for treating sickle cell disease and transfusion-dependent beta thalassemia. This marked a significant…

Continue ReadingCRISPR in the Clinic: Gene-Editing Therapies Transforming Disease Treatment and Patient Lives